Smead Capital Management disclosed 27 US equity positions worth $2.3bn in its Q1 2016 13F filing. Its largest position is NVR at 7.0% of the reported book, followed by Amgen Incorporated and Berkshire Hathaway Cl B. Versus Q4 2015 it opened 6 new positions, added to 0, reduced 21 and exited 6.
$2.3bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
27
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
7.0%
Largest position
The largest single position as a share of the reported equity book.
50.7%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
24
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.